Literature DB >> 32317525

Management of transfusion needs in a case of immunizing anti-M antibody in a patient with acute myeloid leukemia.

Anisha Navkudkar1, Priti Desai1, Rajesh Thakkar1, Sunil Rajadhyaksha1.   

Abstract

Anti-M is a relatively common "naturally occurring" antibody. Unexpected alloantibodies in patient's serum other than ABO isoagglutinins (e.g., anti-M) may cause a discrepancy in the reverse grouping. As long as anti-M does not react at 37°C, it is clinically insignificant for transfusion. However, we found this antibody to be of "immunizing" type which was reactive at 37°C and AHG phase and showing problems in blood grouping and crossmatch. This antibody had both IgM and IgG components. When "M" antibodies active at 37°C are encountered, antigen-negative or red cells that are compatible with an indirect antiglobulin test should be provided.

Entities:  

Keywords:  Anti-M; immunizing; indirect antiglobulin test phase

Year:  2020        PMID: 32317525     DOI: 10.4103/IJPM.IJPM_166_19

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  1 in total

1.  Anti-M antibody and ABO blood grouping discrepancy: a report of three cases with review of literature.

Authors:  Shirin Ferdowsi; Saeed Mohammadi; Moharram Ahmadnezhad; Fahimeh Herfat; Azita Rezvani; Peyman Eshghi; Arezoo Oodi
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.